Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service
NOTTINGHAM, England, Dec. 15, 2020 /PRNewswire/ Oxford Nanopore Technologies Limited ( Oxford Nanopore ), a leading next generation DNA/RNA sequencing technology company and SourceBio International plc ( SourceBio ), an international provider of integrated state of the art laboratory services and products, announce a strategic commercial partnership to offer a commercially available COVID-19 testing solution to corporate customers wishing to provide high quality testing to their employees or other stakeholders, at scale. The test will also be offered to consumers.
If you are a company or organization wishing to deploy testing for your teams, please contact us using this form: https://register.nanoporetech.com/lampore-source-bioscience. If you are a private individual wishing to have a COVID test, please use this link https://coviduk.sourcebioscience.com.